FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2742297576> ?p ?o ?g. }

• W2742297576 endingPage "210" @default.
• W2742297576 startingPage "205" @default.
• W2742297576 abstract "To determine factors influencing compliance in patients with neovascular age-related macular degeneration (n-AMD) undergoing intravitreal anti-vascular endothelial growth factor (VEGF) therapy.The files of n-AMD patients recommended treatment with ranibizumab were reviewed retrospectively. The treatment regimen was 3 consecutive monthly injections followed by monthly follow-up with intravitreal injections as needed (pro re nata, PRN). Demographic and ocular characteristics were recorded. The patients were categorized into 2 groups: full compliance to treatment, or incomplete loading schedule and/or irregular maintenance treatment. All patients were interviewed by phone about factors affecting continuation of treatment.Mean age of the 314 patients (160 female, 154 male) included in the study was 71.6±9.1 years. A total of 246 patients (78.3%) could complete 3 consecutive injections at 1-month intervals after the start of treatment; 57 patients (18.2%) did not attend monthly follow-up during the 1-year follow-up period following the 3 consecutive monthly injections. Overall, 39.8% of the patients were not able to fully comply with the ranibizumab treatment by PRN regimen for 1 year. Better visual acuity at baseline, smaller lesion size, living closer to the hospital, higher education and sociocultural level, and better financial status were determined as factors affecting patient compliance. The most frequent reasons to discontinue treatment were fear of injection, disbelief in the benefit of the treatment, financial limitations, continuation of treatment at another center, and comorbid systemic diseases.Patient compliance and success rates of anti-VEGF therapy may be increased by determining the factors affecting patient compliance and raising awareness about n-AMD among patients and their relatives." @default.
• W2742297576 created "2017-08-17" @default.
• W2742297576 creator A5011536847 @default.
• W2742297576 creator A5017616525 @default.
• W2742297576 creator A5038291255 @default.
• W2742297576 creator A5044453081 @default.
• W2742297576 creator A5047284592 @default.
• W2742297576 creator A5055584183 @default.
• W2742297576 creator A5088835582 @default.
• W2742297576 date "2017-08-09" @default.
• W2742297576 modified "2023-10-17" @default.
• W2742297576 title "Factors Affecting Compliance to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration" @default.
• W2742297576 cites W1500728559 @default.
• W2742297576 cites W1737347230 @default.
• W2742297576 cites W1789824814 @default.
• W2742297576 cites W1969649694 @default.
• W2742297576 cites W1992612246 @default.
• W2742297576 cites W2007104622 @default.
• W2742297576 cites W2017194458 @default.
• W2742297576 cites W2068742492 @default.
• W2742297576 cites W2078326688 @default.
• W2742297576 cites W2085712747 @default.
• W2742297576 cites W2124415048 @default.
• W2742297576 cites W2127486928 @default.
• W2742297576 cites W2154073405 @default.
• W2742297576 cites W2157204458 @default.
• W2742297576 cites W2160726762 @default.
• W2742297576 cites W2322467860 @default.
• W2742297576 cites W2738996050 @default.
• W2742297576 cites W2915852396 @default.
• W2742297576 cites W2991774595 @default.
• W2742297576 doi "https://doi.org/10.4274/tjo.28003" @default.
• W2742297576 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5563548" @default.
• W2742297576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28845324" @default.
• W2742297576 hasPublicationYear "2017" @default.
• W2742297576 type Work @default.
• W2742297576 sameAs 2742297576 @default.
• W2742297576 citedByCount "62" @default.
• W2742297576 countsByYear W27422975762018 @default.
• W2742297576 countsByYear W27422975762019 @default.
• W2742297576 countsByYear W27422975762020 @default.
• W2742297576 countsByYear W27422975762021 @default.
• W2742297576 countsByYear W27422975762022 @default.
• W2742297576 countsByYear W27422975762023 @default.
• W2742297576 crossrefType "journal-article" @default.
• W2742297576 hasAuthorship W2742297576A5011536847 @default.
• W2742297576 hasAuthorship W2742297576A5017616525 @default.
• W2742297576 hasAuthorship W2742297576A5038291255 @default.
• W2742297576 hasAuthorship W2742297576A5044453081 @default.
• W2742297576 hasAuthorship W2742297576A5047284592 @default.
• W2742297576 hasAuthorship W2742297576A5055584183 @default.
• W2742297576 hasAuthorship W2742297576A5088835582 @default.
• W2742297576 hasBestOaLocation W27422975761 @default.
• W2742297576 hasConcept C118487528 @default.
• W2742297576 hasConcept C126322002 @default.
• W2742297576 hasConcept C15744967 @default.
• W2742297576 hasConcept C187212893 @default.
• W2742297576 hasConcept C2776403814 @default.
• W2742297576 hasConcept C2776694085 @default.
• W2742297576 hasConcept C2777802072 @default.
• W2742297576 hasConcept C2778257484 @default.
• W2742297576 hasConcept C2780699112 @default.
• W2742297576 hasConcept C2781100027 @default.
• W2742297576 hasConcept C2781413609 @default.
• W2742297576 hasConcept C2781460075 @default.
• W2742297576 hasConcept C71924100 @default.
• W2742297576 hasConcept C77805123 @default.
• W2742297576 hasConceptScore W2742297576C118487528 @default.
• W2742297576 hasConceptScore W2742297576C126322002 @default.
• W2742297576 hasConceptScore W2742297576C15744967 @default.
• W2742297576 hasConceptScore W2742297576C187212893 @default.
• W2742297576 hasConceptScore W2742297576C2776403814 @default.
• W2742297576 hasConceptScore W2742297576C2776694085 @default.
• W2742297576 hasConceptScore W2742297576C2777802072 @default.
• W2742297576 hasConceptScore W2742297576C2778257484 @default.
• W2742297576 hasConceptScore W2742297576C2780699112 @default.
• W2742297576 hasConceptScore W2742297576C2781100027 @default.
• W2742297576 hasConceptScore W2742297576C2781413609 @default.
• W2742297576 hasConceptScore W2742297576C2781460075 @default.
• W2742297576 hasConceptScore W2742297576C71924100 @default.
• W2742297576 hasConceptScore W2742297576C77805123 @default.
• W2742297576 hasIssue "4" @default.
• W2742297576 hasLocation W27422975761 @default.
• W2742297576 hasLocation W27422975762 @default.
• W2742297576 hasLocation W27422975763 @default.
• W2742297576 hasLocation W27422975764 @default.
• W2742297576 hasOpenAccess W2742297576 @default.
• W2742297576 hasPrimaryLocation W27422975761 @default.
• W2742297576 hasRelatedWork W1604250290 @default.
• W2742297576 hasRelatedWork W2121621777 @default.
• W2742297576 hasRelatedWork W2226641261 @default.
• W2742297576 hasRelatedWork W2423236056 @default.
• W2742297576 hasRelatedWork W2522975619 @default.
• W2742297576 hasRelatedWork W2801834735 @default.
• W2742297576 hasRelatedWork W2967930139 @default.
• W2742297576 hasRelatedWork W3205909906 @default.
• W2742297576 hasRelatedWork W4281630725 @default.
• W2742297576 hasRelatedWork W3122143690 @default.

• next